See how advanced single-cell screening is driving adoptive cell therapy innovation.
Learn how function-first screening accelerates therapeutic target discovery and development.
Ensure only the best-performing immune cells move forward in development.
Discover how single-cell analysis is uncovering biomarkers crucial for personalized therapies.
Learn how optofluidic technology accelerates discovery, enhances validation, and drives clinical translation in cell therapy development.
Usher in the future of cell therapy personalized medicine by identifying effective TCR/CAR sequences using function forward screening
Characterize the performance of CAR-T. TCR,T and T cells at a single-cell level to unlock critical insights into cellular heterogeneity
Uncover powerful clinical biomarkers with deeper understanding of donor heterogeneity and cellular functionality
Bruker Cellular Analysis
With the Beacon Quest Platform, Bruker empowers researchers to accelerate CAR/TCR discovery, make the most of valuable samples, and uncover key biomarkers. Our cutting-edge single-cell analysis solutions deliver real-time insights that help speed up discoveries and improve therapy development.
and Boost Your Research